RBC Capital Downgrades PTC Therapeutics (PTCT) to Sector Perform
Tweet
Share
E-mailGet Alerts PTCT Hot Sheet
Price: $70.56 --0%
Rating Summary:
17 Buy, 6 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 4 | Down: 7 | New: 30
Rating Summary:
17 Buy, 6 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 4 | Down: 7 | New: 30
Join SI Premium – FREE
RBC Capital downgraded PTC Therapeutics (NASDAQ: PTCT) from Outperform to Sector Perform with a price target of $11.00 (from $56.00).
For an analyst ratings summary and ratings history on PTC Therapeutics click here. For more ratings news on PTC Therapeutics click here.
Shares of PTC Therapeutics closed at $10.84 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nomura/Instinet Downgrades Internet Initiative Japan Inc (3774:JP) (IIJIY) to Neutral
- Bumitama Agri (BAL:SP) PT Raised to SGD2.40 at Macquarie
- Nomura/Instinet Downgrades Petpal Pet Nutrition Technology (300673:CH) to Neutral
Create E-mail Alert Related Categories
Analyst PT Change, DowngradesRelated Entities
RBC CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
